Two developers of technologies for people recovering from strokes have agreed to join hands, netting new funding in the ...

Global CRO Worldwide Clinical Trials has enlisted AI tech firm NetraMark to discover patient subpopulations hidden inside ...

A U.S. congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower ...

The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment ...

As KalVista Pharmaceuticals awaits an FDA decision on its hereditary angioedema (HAE) treatment sebetralstat, the company has ...

The Trump administration has blocked access to multiple data repositories maintained by the National Institutes of Health ...

In the latest of a string of clawbacks, the Department of Health and Human Services (HHS) is now sharing plans to cut ...

If the FDA approves nipocalimab, the long-term data could form part of J&J’s pitch for the gMG market. The labels for ...

Rallybio’s lead program has crashed out. Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare ...

The FDA has granted a de novo clearance to a vibrating mattress pad for hospital bassinets, designed to stimulate rhythmic ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...